PRIMA-1 and PRIMA-1(Met) (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies

Por Perdrix, Anne, Najem, Ahmad, Saussez, Sven, Awada, Ahmad, Journe, Fabrice, Ghanem, Ghanem, Krayem, Mohammad
Publicado no Cancers (Basel) (2017)

Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma

Por Krayem, Mohammad, Najem, Ahmad, Journe, Fabrice, Morandini, Renato, Sales, François, Awada, Ahmad, Ghanem, Ghanem E.
Publicado no Oncotarget (2018)

Toad Venom Antiproliferative Activities on Metastatic Melanoma: Bio-Guided Fractionation and Screening of the Compounds of Two Different Venoms

Por Soumoy, Laura, Wells, Mathilde, Najem, Ahmad, Krayem, Mohammad, Ghanem, Ghanem, Hambye, Stéphanie, Saussez, Sven, Blankert, Bertrand, Journe, Fabrice
Publicado no Biology (Basel) (2020)

Metabolic Reprogramming in Metastatic Melanoma with Acquired Resistance to Targeted Therapies: Integrative Metabolomic and Proteomic Analysis

Por Soumoy, Laura, Schepkens, Corentin, Krayem, Mohammad, Najem, Ahmad, Tagliatti, Vanessa, Ghanem, Ghanem E., Saussez, Sven, Colet, Jean-Marie, Journe, Fabrice
Publicado no Cancers (Basel) (2020)

The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma

Por Krayem, Mohammad, Sabbah, Malak, Najem, Ahmad, Wouters, An, Lardon, Filip, Simon, Stephane, Sales, François, Journe, Fabrice, Awada, Ahmad, Ghanem, Ghanem E., Van Gestel, Dirk
Publicado no Cancers (Basel) (2019)

Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Pre...

Por Krayem, Mohamad, Aftimos, Philippe, Najem, Ahmad, van den Hooven, Tim, van den Berg, Adriënne, Hovestad-Bijl, Liesbeth, de Wijn, Rik, Hilhorst, Riet, Ruijtenbeek, Rob, Sabbah, Malak, Kerger, Joseph, Awada, Ahmad, Journe, Fabrice, Ghanem, Ghanem E.
Publicado no Cancers (Basel) (2020)